mibefradil has been researched along with nitroglycerin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, GJ; Kobrin, I; Tzivoni, D | 1 |
Armagnijan, D; Caspi, A; Coelho, OR; Davies, GJ; de Albuquerque, DC; Kobrin, I; Reisin, LH; Schneeweiss, A | 1 |
Braat, S; Kadr, H; Kobrin, I; Ramires, JA; Rutsch, W; Tzivoni, D | 1 |
Bittar, N; Frishman, WH; Glasser, S; Habib, G; Pordy, R; Smith, W | 1 |
4 trial(s) available for mibefradil and nitroglycerin
Article | Year |
---|---|
Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Diltiazem; Female; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Tetrahydronaphthalenes | 1997 |
Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazem.
Topics: Adult; Aged; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Prospective Studies; Tetrahydronaphthalenes | 1997 |
Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Double-Blind Method; Electrocardiography, Ambulatory; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Nitroglycerin; Prospective Studies; Tetrahydronaphthalenes; Vasodilator Agents | 1997 |
Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Tolerance; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin; Prospective Studies; Safety; Tetrahydronaphthalenes; Treatment Outcome; Vasodilator Agents | 1998 |